Research Summary
Dr. Ana Velázquez Mañana is a medical oncology fellow at UCSF Helen Diller Family Comprehensive Cancer Center. Prior to moving to the Bay Area, Dr. Velázquez completed her Internal Medicine residency at Mount Sinai Beth Israel in New York City, where she also was a former Chief Resident.Dr. Velázquez is a proud native Puerto Rican and a passionate advocate for diversity and inclusion. She has a long-standing commitment to serving vulnerable, underserved, and minority populations, which has led her to pursue a two-year postdoctoral fellowship as part of the inaugural cohort of UCSF National Clinician Scholars Program. Dr. Velázquez's interests focus on improving oncology care access and the quality of care delivered to underserved and racial minority patients with cancer. She currently studies gaps in care and unmet needs of diverse adults with lung cancer, supported by UCSF Helen Diller Family Comprehensive Cancer Center and UCSF Center for Aging in Diverse Communities. In addition, she leads quality efforts at Zuckerberg San Francisco General Hospital, the city's largest safety-net hospital, supported by ASCO and Stavros Niarchos Foundation three-year grant program on "Improving the Delivery of Cancer Care in Medically Underserved Communities."
Education
- University of Puerto Rico; Mayaguez, PR, BS, 06/2009, Pre-Medicine
- University of Puerto Rico School of Medicine; San Juan, PR, MD, 06/2014, Doctor in Medicine
- Mayo Graduate School; Rochester, MN, MSc, 06/2015, Master’s in Science
- Icahn School of Medicine Mount Sinai Beth Israel; New York, NY, 06/2017, Internal Medicine Residency
- Icahn School of Medicine Mount Sinai Beth Israel, New York, NY, 06/2018, Chief Residency, Fellow in Medical Education
- University of California, San Francisco, CA, Medical Oncology Fellowship
- University of California, San Francisco, CA, National Clinician Scholar
Honors & Awards
- 2016
NIDDK/NHMA Academic Career Development Workshop and Travel Award - 2017
Icahn School of Medicine at Mount Sinai Beth Israel, Dept of Medicine Ira B. Cohen Award - 2019
Association of Northern California Oncologists (ANCO) ASCO Travel Award - 2019
ASCO Conquer Cancer Foundation Merit Award, ASCO Quality Care Symposium - 2019
The Honor Society of Phi Kappa Phi, Love of Learning Award - 2019
AACR Scholar-in-Training Award, Cancer Health Disparities Conference - 2020
Advancing the Science of Cancer in Latinos Conference Travel Scholarship 2020 - 2020
ASCO Conquer Cancer Foundation Merit Award, ASCO Virtual Meeting 2020 - 2020
ASCO Conquer Cancer Foundation, Improving the Delivery of Cancer Care in Medically Underserved Communities funded by the Stavros Niarchos Foundation - 2020
UCSF Helen Diller Family Comprehensive Cancer Center ZSFG Research Award
Selected Publications
- Bernabe-Ramirez C, Velazquez AI, Olazagasti C, Bergerot CD, Bergerot PG, Soto-Perez-de-Celis E, Duma N The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America. View on PubMed
- Velazquez AI, McCoach CE Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer. View on PubMed
- The role of serum lactate dehydrogenase level as a prognostic indicator in resected, high risk melanoma. View on PubMed
- Wander P, Castaneda D, D'Souza L, Singh S, Serouya S, Velazquez AI, Mamun R, Voaklander R, Benias P, Carr-Locke DL Single Center Experience of a New Endoscopic Clip in Managing Nonvariceal Upper Gastrointestinal Bleeding. View on PubMed
- Rosacea-Like Leukemia Cutis: A Case Report. View on PubMed
- Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients. View on PubMed
- Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota. View on PubMed
- Velazquez AI, Brewer JD The epidemiology of melanoma in young adults View on PubMed
- Velazquez AI, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, Markovic SN, Porrata LF Day 100 Absolute Monocyte/Lymphocyte Prognostic Score and Survival Post Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma View on PubMed